Critical Care News

The FDA granted clearance to OptiScan Biomedical Corporation for its OptiScanner 5000 Glucose Monitoring System, which will allow use of the system for monitoring plasma glucose levels and determining dysglycemia in patients in surgical ICUs, according to a press release.

Men who received red blood cell transfusions from women who had ever been pregnant appeared to have an increased risk for death, according to results of a large, retrospective study published in JAMA.

SAN DIEGO — Exposing infants with respiratory syncytial virus bronchiolitis to secondhand smoke increases their risk of inflammation, while suppressing T and B cell responses, according to a recent presentation held at IDWeek 2017.

Clinically significant reductions in pain were seen in children who underwent minor outpatient orthopedic surgery and were treated with either oral morphine or ibuprofen. However, morphine use correlated with significantly more adverse effects, according to results from a study published in the Canadian Medical Association Journal.

Family-reported outcomes of pediatric cardiac patients once supported by extracorporeal membrane oxygenation, or ECMO, were encouraging, according to findings published in Pediatric Critical Care Medicine.

A novel IV formulation of meloxicam, a therapy in development to manage moderate to severe pain, demonstrated safety and tolerability in patients for up to 7 days after major surgery and significantly lowered their total opioid use compared with placebo, according to phase 3 study data presented at PAINWeek.

Despite many patients returning to work immediately after their first MI, 1 in 4 leave work within 1 year of returning, according to findings from a Danish study.

The rate of hospitalizations in the cardiac ICU for primary cardiac diagnoses has decreased from 2003 to 2013 as the number of hospitalizations for primary noncardiac diagnoses increased, according to a study published in Circulation: Cardiovascular Quality and Outcomes.

The length of time for opioid prescriptions after surgery should vary depending on the type of procedure, according to research recently published in JAMA Surgery.

Use of inhaled nitric oxide in high-risk preterm infants between 5 and 24 days of birth was safe but did not improve survival without broncopulmonary dysplasia under certain circumstances, according to findings recently published in JAMA Pediatrics.